C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
11/1998
11/05/1998	CA2288351A1 Chimeric opg polypeptides
11/05/1998	CA2287910A1 Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds
11/05/1998	CA2287876A1 Rat st38.2 chemokine
11/05/1998	CA2286861A1 Method for cleavage of fusion proteins
11/04/1998	EP0875578A2 Penicllin binding protein 2A from staphylococcus aureus strain 27R and derivatives for use in purification therefor and assay for compounds effective against methicillin resistant organisms
11/04/1998	EP0874903A1 Humanized green fluorescent protein genes and methods
11/04/1998	EP0754229B1 Alfamin: a human serum albumin-like protein
11/04/1998	EP0656950B1 Tat-derived transport polypeptides
11/04/1998	EP0648228B1 Bnp antibody and immunoassay using it
11/04/1998	CN1040540C Anthracene ring antibiotic thioether conjugates, its prepn. and pharmaceutical composition containing same
11/03/1998	US5831014 PNA combinatorial libraries and improved methods of synthesis
11/03/1998	US5831000 Hybrid calcitonin
11/03/1998	US5830849 Vampire bat salivary plasminogen activators
11/03/1998	US5830770 Immunoassay of pesticides
11/03/1998	US5830756 DNA and expression vector encoding IκB Protein
11/03/1998	US5830706 Polypeptide fusions to polypeptides of the beta-trefoil fold structural family
11/03/1998	US5830703 DNA encoding adrenomedullin
11/03/1998	US5830698 Kit with unique site for recombination of bacterial, insect, viral and synthetic dna
11/03/1998	US5830663 Human heavy and light chain variable domains, genes rescued from popultions of cells by ?in-cell? pcr
11/03/1998	CA1340111C Vectors and compounds for expression of zymogen forms of human protein c
10/1998
10/29/1998	WO1998048024A1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
10/29/1998	WO1998048017A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
10/29/1998	WO1998047921A1 Mammalian cytokines; related reagents and methods
10/29/1998	CA2287254A1 Mammalian cytokines; related reagents and methods
10/29/1998	CA2286933A1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
10/28/1998	EP0874054A2 Vector for the expression of immunoglobulin-cytokine fusionproteins in malignant B Cells
10/28/1998	EP0874051A2 OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines.
10/28/1998	EP0873999A1 Antibody to the prorenin profragment, renin-active substance containing the same and prorenin assay reagent using the same
10/28/1998	EP0873349A1 Endothelial-monocyte activating polypeptide iii
10/28/1998	EP0407392B2 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES
10/27/1998	US5827934 Cytotoxic diphtheria toxin fragments
10/27/1998	US5827818 Anticoagulants; administered by injections along with a carrier
10/27/1998	US5827817 P-selectin ligand protein
10/27/1998	US5827816 Bactericide for gram-negative bacteria infection; a polypeptide with a cysteine at position 132 replaced by different amino acid
10/27/1998	US5827668 Immunodiagnostic assay for rheumatoid arthritis
10/22/1998	WO1998046642A1 MODIFIED TNFα MOLECULES, DNA ENCODING SUCH MODIFIED TNFα MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFα MOLECULES AND DNA
10/22/1998	WO1998046636A2 β-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
10/22/1998	WO1998046257A1 Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods
10/22/1998	CA2289476A1 Modified tnf.alpha. molecules, dna encoding such modified tnf.alpha. molecules and vaccines comprising such modified tnf.alpha. molecules and dna
10/22/1998	CA2286484A1 .beta.-amyloid peptide-binding proteins and polynucleotides encoding the same
10/21/1998	EP0871720A2 Beta-secretase, antibodies to beta-secretase, and assays for detecting beta-secretase inhibition
10/21/1998	EP0871704A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor
10/21/1998	EP0871670A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR
10/21/1998	EP0871648A1 A high throughput assay using fusion proteins
10/21/1998	EP0871495A1 Redirection of cellular immunity by receptor chimeras
10/21/1998	EP0871492A2 Mesothelium antigen and methods and kits for targeting it
10/21/1998	EP0658199B1 Production of heterodimer pdgf-ab by means of a bicistronic vector system in mammalian cells
10/21/1998	EP0529065B1 Receptor-based screening methods for amylin agonists and antagonists
10/20/1998	US5824840 Diabetes-inducing transgenic mouse
10/20/1998	US5824788 Cloning of gene encoding the GP28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications
10/20/1998	US5824776 Cell-targeted lytic pore-forming agents
10/20/1998	US5824492 Polypeptides having kinase activity, their preparation and use
10/20/1998	CA1340097C Synthetic antigen for detection of aids-related disease
10/15/1998	WO1998045434A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor
10/15/1998	WO1998045427A2 Insulin-like growth factor agonist peptides
10/15/1998	CA2286264A1 Insulin-like growth factor agonist peptides
10/15/1998	CA2285020A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor
10/14/1998	EP0870039A1 Recombinant fusion proteins to growth hormone and serum albumin
10/14/1998	EP0870037A2 Methods and compositions for synthesis of oligosaccharides using mutant glycosidase enzymes
10/14/1998	EP0870026A1 Ob protein derivatives having prolonged half-life
10/14/1998	EP0870024A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/14/1998	EP0870023A1 Osteoprotegerin
10/14/1998	EP0869973A2 Mammalian chemokine ccf8 and chemokine receptor cckr3
10/14/1998	EP0869802A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions
10/14/1998	EP0628054B1 Car receptors and related molecules and methods
10/14/1998	CN1195667A Novel antibody, renin-active substance containing same and prorenin assay reagent using the same
10/13/1998	US5821337 Immunoglobulin variants
10/13/1998	US5821336 Polypeptide having specified amino acid sequence or fragment thereof
10/13/1998	US5821333 Method for making heteromultimeric polypeptides
10/13/1998	US5821238 Administering to patient to impair tumor growth
10/13/1998	US5821123 Modified antibody variable domains
10/13/1998	US5821065 Immunoassay for the detection of collagen I
10/13/1998	US5821051 Combining e6 protein, e6 binding protein, and test compound,detecting formation of complex; identifying agents which affect protein binding; human papillomavirus
10/13/1998	US5821047 Fusing a gene encoding a protein of interest to the carboxy terminal domain of the gene iii coat protein of the filamentous phage m13; mutation to form library; expressed in low quantity on surface of phagemid particle
10/13/1998	US5820866 Product and process for T cell regulation
10/13/1998	CA1340081C Class of low calorie protein sweeteners
10/08/1998	WO1998044132A1 VIRAL VECTORS HAVING CHIMERIC ENVELOPE PROTEINS CONTAINING THE IgG-BINDING DOMAIN OF PROTEIN A
10/08/1998	WO1998044129A1 Enhancement of immune response using targeting molecules
10/08/1998	WO1998044119A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)
10/08/1998	WO1998044107A1 Diagnosis and prognosis of glaucoma
10/08/1998	WO1998025959A3 Secreted human proteins
10/08/1998	WO1998016646A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/08/1998	CA2285692A1 Enhancement of immune response using targeting molecules
10/08/1998	CA2285625A1 Nucleic acid fragments and polypeptide fragments derived from m. tuberculosis
10/07/1998	EP0869133A1 Production of gonorrheal PIB proteins and vaccines
10/07/1998	EP0868920A2 Hybrid protein for treatment of bladder cancer cells
10/07/1998	EP0868521A2 Globins containing binding domains
10/07/1998	EP0868513A1 TGF$g(b) SIGNAL TRANSDUCTION PROTEINS, GENES, AND USES RELATED THERETO
10/07/1998	EP0868435A1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein
10/07/1998	EP0868198A1 FC$g(e)-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
10/06/1998	US5817790 Reshaped human antibody to human interleukin-6 receptor
10/06/1998	US5817789 Bind to cell surface receptors; genetic engineering
10/06/1998	US5817771 Cell-targeted lytic pore-forming agents
10/06/1998	US5817767 Synergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using same
10/06/1998	US5817622 Cloning dna sequences
10/06/1998	US5817513 Immunotherapy for cancer
10/06/1998	US5817317 Clostridium perfringens vaccines
10/06/1998	US5817316 Immunogenic peptides, antibodies and uses thereof relating to CD4 receptor binding
10/06/1998	CA2082824C Pseudomonas exotoxin multifunctional fusion proteins having carboxyl alterations with increased cytotoxicity
10/01/1998	WO1998042850A1 Anticoagulant fusion protein anchored to cell membrane

1 ... 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 ... 295